Outlook Therapeutics, Inc.

Contributing Author

Recent Articles by Outlook Therapeutics, Inc.

May-23	Outlook Therapeutics Announces Pricing of $13.0 Million Public Offering OTLK GlobeNewswire
May-22	Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants OTLK GlobeNewswire
May-15	Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update OTLK GlobeNewswire